| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/06/2005 | US20050003489 Conformational and topological protein regulation |
| 01/06/2005 | US20050003487 Chordin dorsalizing and hemoglobin inducing polypeptides and nucleic acids encoding the same |
| 01/06/2005 | US20050003484 Modified antigen-presenting cells |
| 01/06/2005 | US20050003482 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics |
| 01/06/2005 | US20050003477 Expression vector comprising nucleotide sequences coding brain cyclic nucleotide gated ion channel (BCNG) protein for use in treatment and prevention of nervous system, urogenital and cardiovascular disorders |
| 01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 01/06/2005 | US20050003472 Process for the staining of sperm |
| 01/06/2005 | US20050003460 Identifying progenitor cell populations comprising at least one disaccharide repeat of glucuronic acid and n-acetylglucosamine and enhanced hyaluronic acid synthase expression for use in tissue repair and treatment and prevention of cancer and/or skin disorders. |
| 01/06/2005 | US20050003458 Method and system for the analysis of high density cells samples |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003456 Method for separating hepatic progenitor cell |
| 01/06/2005 | US20050003454 Conformational and topological protein regulation |
| 01/06/2005 | US20050003453 G-CSF analog compositions and methods |
| 01/06/2005 | US20050003452 Fusion protein comprising membrane translocation sequences for use in identifying modulators for treatment and prevention of cell proliferative disorders |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003446 Peptide sequences for use in identification of modulators for use in treatment and prevention of inflammatory, cell proliferative, arteriosclerotic and skin disorders |
| 01/06/2005 | US20050003442 Delta4-desaturase genes and uses thereof |
| 01/06/2005 | US20050003439 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 01/06/2005 | US20050003438 Conformational and topological protein regulation |
| 01/06/2005 | US20050003436 Release of intracellular material |
| 01/06/2005 | US20050003419 Enhanced enzymatic polypeptide for use as component of cleaning compound; detergents; papermaking; textiles |
| 01/06/2005 | US20050003415 Media and methods for promoting maturation of conifer somatic embryos |
| 01/06/2005 | US20050003412 Protein activator of superoxide production for use in treatment and prevention of cancer, psoriasis, prostatic hypertrophy, benign prostatic hypertrophy and cardiovascular disease |
| 01/06/2005 | US20050003407 Genomic DNA fragments containing regulatory and coding sequence for the beta2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments |
| 01/06/2005 | US20050003401 Expression vector comprising nucleotide sequences coding archaeal replication factor A (RFA) for use in generating polypeptide which enhances stability and efficacy of gene amplification products |
| 01/06/2005 | US20050003400 Using osteoprotegrin binding agent as tool in identifying modulator for treatment and prevention of osteoporosis and bone disorders |
| 01/06/2005 | US20050003391 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response |
| 01/06/2005 | US20050003383 Linoleate isomerase |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050003367 Methods and compositions for rapid development of screening assays |
| 01/06/2005 | US20050003365 Transgenic cells comprising nucleotide sequences coding fetal liver kinase-1 receptors; for use self-renewal of totipotent hematopoietic stem cell and to stimulate the development of all cells of the hematopoietic system both in vitro and in vivo |
| 01/06/2005 | US20050003353 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/06/2005 | US20050003352 Comprises recombinant mitochondrial transport protein for diagnosis, prevention and treatment of alzheimer's, diabetes, parkinson's, huntington's, cancers |
| 01/06/2005 | US20050003348 Drug screening/design; crystal structure; replication-defective |
| 01/06/2005 | US20050002985 Device with recessed tracks for forming a cellular network |
| 01/06/2005 | US20050002965 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 01/06/2005 | US20050002955 Acquired Immune Deficiency Syndrome (AIDS) diagnosis and treatment |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002940 Cancerous disease modifying antibodies |
| 01/06/2005 | US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/06/2005 | US20050002937 Anti-IL-12 antibodies, compositions, methods and uses |
| 01/06/2005 | US20050002933 Proliferation and/or differentiation of stem and progenitor cells from embryo or adult |
| 01/06/2005 | US20050002932 Alleviation of symptoms associated with inflammatory disease states |
| 01/06/2005 | US20050002920 Collecting, activating, culturing and optionally expanding peripheral blood mononuclear cells then hypomethylating with 5-aza-cytidine or 5-aza-2'-deoxycytidine |
| 01/06/2005 | US20050002919 Using modified cells for drug, diagnostic agent and/or toxin delivery to target tissues; novel genetically altered human progenitor cells |
| 01/06/2005 | US20050002915 Enhancement of angiogenesis to grafts using cells engineered to produce growth factors |
| 01/06/2005 | US20050002914 Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
| 01/06/2005 | US20050002912 Repairing myocardium with cells induced to contract spontaneously; electrically stimulating myogenic cells while culturing in vitro then implanting |
| 01/06/2005 | US20050002910 Flowing nutrient solution into, through and out of ground demineralized cells in bioreactor; tissue engineered material |
| 01/06/2005 | US20050002908 Method for producing a recombinant adeno-associated virus, suitable means therefor and use for producing a medicament |
| 01/06/2005 | CA2839032A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/06/2005 | CA2530422A1 Postpartum-derived cells for use in treatment of disease of the heart and circulatory system |
| 01/06/2005 | CA2530255A1 Soft tissue repair and regeneration using postpartum-derived cells |
| 01/06/2005 | CA2530020A1 Novel .beta.-actin and rps21 promoters and uses thereof |
| 01/06/2005 | CA2529943A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy |
| 01/06/2005 | CA2529941A1 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 01/06/2005 | CA2529143A1 Methods of producing neurons |
| 01/06/2005 | CA2528544A1 Compositions and methods for regulating polysaccharides of a plant cell |
| 01/06/2005 | CA2528511A1 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 01/06/2005 | CA2526080A1 Polypeptides that bind an anti-tissue factor antibody and uses thereof |
| 01/06/2005 | CA2526023A1 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 01/06/2005 | CA2525596A1 Allogeneic cell therapy: mirror effect |
| 01/06/2005 | CA2525251A1 Cd20-specific antibodies and methods of employing same |
| 01/05/2005 | EP1494019A1 Method and arrangement for investigation of biological materials |
| 01/05/2005 | EP1494008A1 Method and system for simultaneously imaging multiple views of a plant embryo |
| 01/05/2005 | EP1493817A1 Resistance against plant pests |
| 01/05/2005 | EP1493812A2 A truncated keratinocyte growth factor (KGF) having increased biological activity |
| 01/05/2005 | EP1493805A1 Cell culture system, apparatus for checking cultured cells and apparatus for culturing cells |
| 01/05/2005 | EP1493035A1 Method for selecting bioactive agents by detecting variation induced in cyclic amp intracellular concentration of a sensitive living cell |
| 01/05/2005 | EP1493028A2 Phage displayed pdz domain ligands |
| 01/05/2005 | EP1492890A2 Large scale methods of producing adenovirus and adenovirus seed stocks |
| 01/05/2005 | EP1492874A1 Multigenic vector plasmids and methods for increasing expression of recombinant polypeptides |
| 01/05/2005 | EP1492870A2 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
| 01/05/2005 | EP1492869A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 01/05/2005 | EP1492817A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 01/05/2005 | EP1492815A2 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner |
| 01/05/2005 | EP1492813A2 Ox40r binding agents |
| 01/05/2005 | EP1492811A1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 01/05/2005 | EP1492806A2 Human smooth muscle myosin heavy chain |
| 01/05/2005 | EP1492565A2 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty |
| 01/05/2005 | EP1492563A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/05/2005 | EP1492559A2 Truncated 24 kda basic fibroblast growth factor |
| 01/05/2005 | EP1492555A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell population |
| 01/05/2005 | EP1492475A2 Dense/porous structures for use as bone substitutes |
| 01/05/2005 | EP1492438A2 Device and method to maintain vascularization near implant |
| 01/05/2005 | EP1492410A1 Triglyceride fat |
| 01/05/2005 | EP1492404A2 Novel spinosyn-producing polyketide synthases |
| 01/05/2005 | EP1441602A4 Molecular press dehydration method for vegetative tissue using the solid phase of water soluble polymer substances as a dehydrating agent |
| 01/05/2005 | EP1423504A4 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof |
| 01/05/2005 | EP1412481A4 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 01/05/2005 | EP1393067A4 Encapsulated cell indicator system |
| 01/05/2005 | EP1290141A4 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
| 01/05/2005 | EP1218492A4 Method and system for non-random selection of plant and tissue products |
| 01/05/2005 | EP1211933A4 Pa28 modified transgenic mice |
| 01/05/2005 | EP1102841A4 Method for selective and optionally reversible degeneration of somatic plant tissue |
| 01/05/2005 | EP0994956B1 Male tissue-preferred regulatory region and method of using same |
| 01/05/2005 | EP0837930B1 A TRP-226 MUTANT HUMAN GLANDULAR KALLIKREIN-1 (hK2) |
| 01/05/2005 | EP0730609B1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 01/05/2005 | EP0719333B1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |